Clinical trial
Noncontrast CT-Based Deep Learning for Predicting Hematoma Expansion Risk in Patients with Spontaneous Intracerebral Hemorrhage
NCT06602115 is registered in ClinicalTrials.gov with Qiang Yu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Noncontrast CT-Based Deep Learning for Predicting Hematoma Expansion Risk in Patients with Spontaneous Intracerebral Hemorrhage
- Lead sponsor
- Qiang Yu
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 25, 2024
- Completion date
- December 31, 2024
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hematoma expansion, spontaneous intracerebral hemorrhage